|
RNF5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.552000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.206100E-02 |
| Normal-vs-Stage2 |
5.568000E-01 |
| Normal-vs-Stage3 |
1.488040E-02 |
| Normal-vs-Stage4 |
2.750800E-01 |
| Stage1-vs-Stage2 |
1.253210E-01 |
| Stage1-vs-Stage3 |
3.178600E-04 |
| Stage1-vs-Stage4 |
2.531600E-02 |
| Stage2-vs-Stage3 |
2.787200E-01 |
| Stage2-vs-Stage4 |
7.108400E-01 |
| Stage3-vs-Stage4 |
5.388800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.424200E-01 |
| Normal-vs-AfricanAmerican |
6.715600E-01 |
| Normal-vs-Asian |
8.344800E-03 |
| Caucasian-vs-AfricanAmerican |
7.700000E-01 |
| Caucasian-vs-Asian |
1.838620E-01 |
| AfricanAmerican-vs-Asian |
1.890790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.205800E-02 |
| Normal-vs-Female |
7.476300E-03 |
| Male-vs-Female |
3.14499999998219E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.833990E-02 |
| Normal-vs-Age(41-60Yrs) |
6.738400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.094000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.547600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.072300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.618400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.919590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.593400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.080200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.419600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.278200E-03 |
| Normal-vs-Grade 2 |
1.235550E-01 |
| Normal-vs-Grade 3 |
9.171600E-01 |
| Normal-vs-Grade 4 |
1.65569999999171E-06 |
| Grade 1-vs-Grade 2 |
2.451800E-02 |
| Grade 1-vs-Grade 3 |
1.312070E-02 |
| Grade 1-vs-Grade 4 |
2.35689999994459E-06 |
| Grade 2-vs-Grade 3 |
2.065200E-01 |
| Grade 2-vs-Grade 4 |
6.80589995472047E-09 |
| Grade 3-vs-Grade 4 |
4.81439999999722E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.9686700026873E-12 |
| Normal-vs-ccB subtype |
1.62803104331033E-12 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.266600E-01 |
| Normal-vs-N1 |
2.129700E-02 |
| N0-vs-N1 |
1.525970E-02 |
|
|
